Sangare MN, Baril JG, de Pokomandy A, Klein M, et al. CD4/CD8 ratio outcome according to the class of the third active drug in antiretroviral therapy (ART) regimens: results from the Quebec Human Immunodeficiency Virus (HIV) Cohort Study. Clin Infect Dis 2023 Feb 1:ciad056. doi: 10.1093.
PMID: 36722329